The APRNs Complete Guide to Prescribing Drug Therapy – A quick-access guide to current drug recommendations with regular digital updates!
The APRNs Complete Guide to Prescribing Drug Therapy is a prescribing reference intended for use by health care providers in all clinical practice settings who are involved in the primary care management of patients with acute, episodic, and chronic health problems. It is organized in a concise and easy-to-read format. Comments are interspersed throughout, including such clinically useful information as laboratory values to be monitored, patient teaching points, and safety information.
This reference is divided into two major sections that are organized in a concise and easy-to-read format, Section I presents drug treatment regimens for over 500 clinical diagnoses. Each drug is listed alphabetically by generic name, whether the drug is available over the counter (OTC), DEA schedule (I, II, III, IV, V), generic availability (G), adult and pediatric dosing regimens, available dose forms, whether tablets, caplets, or chew tabs are scored (), cross-scored (), or tri-scored (), fl avors of chewable, sublingual, buccal, and liquid forms, and information regarding additives (e.g., dyefree, sugar-free, preservative-free or preservative type, and alcohol-free or alcohol content). For drugs initially FDA-approved prior to June 30, 2015, the former traditional FDA pregnancy categories still apply (A, B, C, D, or X). Non-pharmaceutical products, and drugs that received initial FDA-approval on or aft er June 30, 2015 do not have an FDA pregnancy designation. For information regarding special populations.
Section II presents clinically useful information in convenient table format, including: the JNC-8 recommendations for hypertension management, the U.S. schedule of controlled substances and the FDA pregnancy categories, measurement conversions, childhood and adult immunization recommendations, brand-name drugs (with contents) for the management of common respiratory symptoms, anti-infectives by classifi cation, pediatric dosing by weight for liquid forms, glucocorticosteroids by potency and route of administration, and contraceptives by route of administration and estrogen and/or progesterone content. An alphabetical index of drugs by generic and brand name, with FDA pregnancy category and controlled drug schedule, facilitates quick identifi cation of drugs by alternate names, relative safety during pregnancy, and DEA schedule.
Selected diagnoses (e.g., angina, ADHD, growth failure, glaucoma, Parkinson’s disease, CMV retinitis, multiple sclerosis, cystic fi brosis) and selected drugs (e.g., antineoplastics, antipsychotics, anti-arrhythmics, anti-HIV drugs, and anticoagulants) are included as patients are oft en referred by surgeons and emergency and urgent care providers to the primary care provider for follow-up monitoring and management.